scispace - formally typeset
Z

Zhaohui Huang

Researcher at Jiangnan University

Publications -  99
Citations -  4798

Zhaohui Huang is an academic researcher from Jiangnan University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 29, co-authored 74 publications receiving 3792 citations. Previous affiliations of Zhaohui Huang include Soochow University (Suzhou) & Northwestern University.

Papers
More filters
Journal ArticleDOI

Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.

TL;DR: Investigation of whether plasma miRNAs can be used as biomarkers for the early detection of colorectal carcinoma found that plasma miR‐29a and miR-92a have significant diagnostic value for advanced neoplasia and combined ROC analyses suggest that they have strong potential as novel noninvasive biomarkers.
Journal ArticleDOI

LncRNA—UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p

TL;DR: The present work provides the first evidence of a UCA1-miR-204-5p-CREB1/BCL2/RAB22A regulatory network in CRC and reveals that U CA1 and CREB1 are potential new oncogenes and prognostic factors for CRC.
Journal ArticleDOI

Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.

TL;DR: Low levels of plasma miR-601 andMiR-760 can potentially serve as promising non-invasive biomarkers for the early detection of colorectal cancer.
Journal ArticleDOI

LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling.

TL;DR: Mechanistic insights are provided into the regulation of FEZF1-AS1 on both STAT3 signaling and glycolysis by binding PKM2 and increasing its stability by binding and increasing the stability of pyruvate kinase 2.
Journal ArticleDOI

A Positive Feedback Loop of lncRNA-PVT1 and FOXM1 Facilitates Gastric Cancer Growth and Invasion.

TL;DR: PVT1 may be a valuable prognostic predictor for gastric cancer, and the positive feedback loop of PVT1-FOXM1 could be a therapeutic target in pharmacologic strategies.